about
Role of positron emission tomography for central nervous system involvement in systemic autoimmune diseases: status and perspectives.CADA-computer-aided DaTSCAN analysis.Structural connectivity differences in essential tremor with and without resting tremor.Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT studyDiffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.Blink reflex recovery cycle distinguishes essential tremor with resting tremor from de novo Parkinson's disease: an exploratory study.Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.Coupled Imaging with [18F]FBB and [18F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain.Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.Characterizing structural neural networks in de novo Parkinson disease patients using diffusion tensor imaging.Alterations of putaminal shape in de novo Parkinson's disease.Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study.Midbrain hemiatrophy and nigral rarefaction in a patient with hemiparkinsonism-hemiatrophy syndrome.Diffusion tensor MRI changes in gray structures of the frontal-subcortical circuits in amyotrophic lateral sclerosisIn vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy studyEffect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's diseaseA new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's diseaseAnti-GAD-associated inflammatory myopathy presenting with dropped head syndromeBiological and clinical manifestations of juvenile Huntington's disease: a retrospective analysisDoes levodopa have a disease-modifying effect in Parkinson's disease? Evidence from a delayed-start trialAgeing effect on 18F-DOPA and 123I-MIBG uptake: a cross-sectional studyClinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndromeValue of Multimodal Imaging Approach to Diagnosis of NeurosarcoidosisBrain glucose consumption abnormalities in neuro-Behçet's disease: a preliminary 18F-FDG PET/CT studyApomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's diseaseTrack density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonismIntracellular FMRpolyG-Hsp70 complex in fibroblast cells from a patient affected by fragile X tremor ataxia syndromeImaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI studyThe embodiment of language in tremor-dominant Parkinson's disease patientsBrain metabolic patterns in patients with suspected non-Alzheimer's pathophysiology (SNAP) and Alzheimer's disease (AD): is [18F] FDG a specific biomarker in these patients?Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy
P50
Q36381732-DDFF6FCF-CDE2-47D4-951D-EB06C764485EQ36582004-63C24DDF-8C49-4B6A-B280-DB9138C29F4EQ38668648-12177CFB-6BF6-49B2-8EAA-369F4BB72DE4Q40202363-FAF8CC62-44E5-4364-A63C-A88717981A10Q41108953-61A33E70-70F8-4B93-B452-F73029005AE1Q43899144-A14630BB-2044-441C-9A1D-D55030831C86Q44873351-79D6D6C2-13F8-4D21-9F71-9F1C4C996DC6Q47371791-BB022873-0805-4050-BCDA-DADE80FDE712Q47589923-1FAB528F-E20C-4949-9B45-61610A1D761CQ48101119-05B37053-4386-463C-B2F1-D3AA02504863Q48252241-1B97990E-27FF-42FC-8A01-8F9D93D2915AQ48599732-6F3DAA9F-DCE7-4705-B274-4FAE357908ABQ48866376-FDD2D114-BB49-459E-945A-FF05C597E9C2Q50239691-B253CCE9-7497-4339-9E4D-153DD02BA20FQ51738795-C0E9FC8A-1679-4CEB-9EF5-D4BC9B9216CEQ54190938-8DB6FC03-9ADC-4B8E-8B0A-84B5DA7CBA1EQ57787720-D97412C3-30EE-4068-AE15-1EEEBEB0AA51Q62706265-53C866FA-5192-41CF-819C-DBCB445918D7Q62780751-6FC02D29-A89C-4106-A55E-12347E600E48Q62781709-60AD9606-DA10-4049-B3EA-2BEA1DC27C02Q62781768-00BE8BAD-9FDE-484B-9427-DC2CC0D51087Q64042996-DF87C922-1604-4CCB-AD5C-C9D82F746DBFQ64769000-DA2C4DF9-A837-404C-AABB-C6FDF57F12AAQ88341598-4D2B65B9-D388-4A74-A09D-06D6038AB4C5Q89051258-B5A6C519-D21D-4060-98EE-250AA01F2E4CQ90223648-C4DA13D0-6574-4BEB-98C1-0586BC5C6473Q90735929-9A3D5429-4DFF-4DBA-9C35-FDA2FD43B5FFQ90766265-BF13FEF6-907D-4534-AA81-01CEF7570301Q91007885-DBCAD2DD-C268-4246-80C7-548E144F9D54Q91787334-A803DFFE-913B-49A9-9713-8705CB4EB19BQ91902007-BE146FF3-2B5F-45D1-8A5E-901A02C56617Q92049659-40022D8E-2BBE-46E8-89E8-FCE6C2961931Q92762069-375FACA6-DBA1-421A-BD0D-74852B1FCAE8Q94587696-B4F49AC8-B4B8-4556-8461-58DD3E06F4C5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Gaetano Barbagallo
@ast
Gaetano Barbagallo
@en
Gaetano Barbagallo
@es
Gaetano Barbagallo
@nl
type
label
Gaetano Barbagallo
@ast
Gaetano Barbagallo
@en
Gaetano Barbagallo
@es
Gaetano Barbagallo
@nl
prefLabel
Gaetano Barbagallo
@ast
Gaetano Barbagallo
@en
Gaetano Barbagallo
@es
Gaetano Barbagallo
@nl
P1053
J-8664-2016
P106
P1153
57023618400
P21
P2798
P31
P496
0000-0002-2237-3006